PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
503.87 - 512.55
344.79 - 555.45
23.62M / 20.39M (Avg.)
37.30 | 13.67
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
50.22%
Some net income increase while PANW is negative at -13.39%. John Neff would see a short-term edge over the struggling competitor.
-4.92%
Negative yoy D&A while PANW is 12.40%. Joel Greenblatt would note a short-term EPS advantage unless competitor invests for future advantage.
102.40%
Some yoy growth while PANW is negative at -37.50%. John Neff would see competitor possibly managing deferrals more aggressively for short-term advantage.
5.87%
SBC growth well above PANW's 4.20%. Michael Burry would flag major dilution risk vs. competitor’s approach.
8.23%
Well above PANW's 15.24% if positive yoy. Michael Burry would see a risk of bigger working capital demands vs. competitor, harming free cash flow.
218.07%
AR growth well above PANW's 102.71%. Michael Burry would fear inflated sales or less stringent credit controls vs. competitor.
-551.56%
Negative yoy inventory while PANW is 800.00%. Joel Greenblatt would see a near-term cash advantage if top-line doesn't suffer.
-2505.88%
Both negative yoy AP, with PANW at -47.06%. Martin Whitman would find an overall trend toward paying down supplier credit in the niche.
-47.18%
Both reduce yoy usage, with PANW at -44.73%. Martin Whitman would suspect an industry or cyclical factor pulling back on these items.
-3.14%
Negative yoy while PANW is 0.00%. Joel Greenblatt would see a near-term net income or CFO stability advantage unless competitor invests or writes down more aggressively.
36.45%
Operating cash flow growth above 1.5x PANW's 8.43%. David Dodd would confirm superior cost control or stronger revenue-to-cash conversion.
18.53%
Some CapEx rise while PANW is negative at -28.22%. John Neff would see competitor possibly building capacity while we hold back expansions.
61.90%
Less M&A spending yoy vs. PANW's 426.56%, reducing near-term risk. David Dodd would confirm the firm is not missing out on a strategic deal that competitor might exploit.
-89.99%
Both yoy lines negative, with PANW at -38.09%. Martin Whitman would suspect an environment with fewer attractive securities or a strategic pivot to internal growth.
79.59%
Proceeds from sales/maturities above 1.5x PANW's 5.28%. David Dodd would confirm if the firm is capitalizing on strong valuations or freeing liquidity for expansions.
-7.69%
Both yoy lines negative, with PANW at -426.56%. Martin Whitman suspects a cyclical or strategic rationale for cutting extra invests in the niche.
-83.36%
Both yoy lines negative, with PANW at -17900.00%. Martin Whitman suspects a broader cyclical shift away from heavy investing across the niche.
-800.00%
We cut debt repayment yoy while PANW is 0.00%. Joel Greenblatt sees competitor possibly lowering risk more if expansions do not hamper them.
39.31%
Issuance growth of 39.31% while PANW is zero at 0.00%. Bruce Berkowitz sees a mild dilution that must be justified by expansions or acquisitions vs. competitor’s stable share base.
-18.63%
We cut yoy buybacks while PANW is 0.00%. Joel Greenblatt would question if competitor is gaining a per-share edge unless expansions justify holding cash here.